Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

Conditions: Tardive Dyskinesia; Huntington Disease Interventions: Drug: LPM3770164 sustained release tablet; Drug: LPM3770164 sustained release tablet simulant Sponsors: Luye Pharma Group Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials